Clinical Trial: A randomized, open-label, single-dose, two-formulation, two-sequence, two-period crossover bioequivalence study of canagliflozin tablets under fasting and fed states in healthy subjects (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, open-label, single-dose, two-formulation, two-sequence, two-period crossover bioequivalence study of canagliflozin tablets under fasting and fed states in healthy subjects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133557

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Guangzhou Panyu Central Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325701

Published by HT Digital Content Services with permission from Health Daily Digest....